These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35416537)

  • 1. Effectiveness of adding alarms to flash glucose monitoring in adults with type 1 diabetes under routine care.
    Boscari F; Ferretto S; Cavallin F; Fadini GP; Avogaro A; Bruttomesso D
    Acta Diabetol; 2022 Jul; 59(7):921-928. PubMed ID: 35416537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent-scanned continuous glucose monitoring with low glucose alarms decreases hypoglycemia incidence in middle-aged adults with type 1 diabetes in real-life setting.
    Oriot P; Hermans MP
    J Diabetes Complications; 2023 Feb; 37(2):108385. PubMed ID: 36603333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of flash glucose monitoring in patients with type 1 diabetes and recurrent hypoglycemia between early and late stages after flash glucose monitoring initiation.
    Contreras M; Mesa A; Pueyo I; Claro M; Milad C; Viñals C; Roca D; Granados M; Giménez M; Conget I
    J Diabetes Complications; 2023 Aug; 37(8):108560. PubMed ID: 37480703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Patient-reported Satisfaction and Metabolic Outcomes Following Initiation of the Second Generation of Flash Glucose Monitoring in Patients with Type 1 Diabetes.
    Al Hayek A; Robert AA; Alzahrani WM; Al Dawish MA
    Curr Diabetes Rev; 2024; 20(4):e100823219628. PubMed ID: 37563819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of switch from flash glucose monitoring to flash glucose monitoring with real-time alarms on hypoglycaemia in people with type 1 diabetes mellitus.
    Gutiérrez-Pastor A; Quesada JA; Soler-Martínez MM; Carratalá Munuera C; Pomares-Gómez FJ
    Prim Care Diabetes; 2024 Jun; 18(3):333-339. PubMed ID: 38677966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Sustained Automated Insulin Delivery Compared With Sensor and Pump Therapy in Adults With Type 1 Diabetes at High Risk for Hypoglycemia: A Randomized Controlled Trial.
    Renard E; Joubert M; Villard O; Dreves B; Reznik Y; Farret A; Place J; Breton MD; Kovatchev BP;
    Diabetes Care; 2023 Dec; 46(12):2180-2187. PubMed ID: 37729080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flash glucose monitoring system in patients with type 1 diabetes in healthcare center in Brazil: real world data from a short-term prospective study.
    Matheus ASM; Pascoal JBF; Cabizuca CA; Tannus LRM; Guimarães RS; Mattos DMF; Cobas RA
    Arch Endocrinol Metab; 2023 Mar; 67(3):289-297. PubMed ID: 36468924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of the freestyle libre 2 flash glucose monitoring system on diabetes-self-management practices and glycemic parameters among patients with type 1 diabetes using insulin pump.
    Al Hayek AA; Robert AA; Al Dawish MA
    Diabetes Metab Syndr; 2021; 15(5):102265. PubMed ID: 34488057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study
    Préau Y; Galie S; Schaepelynck P; Armand M; Raccah D
    Sensors (Basel); 2021 Sep; 21(18):. PubMed ID: 34577338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Glycemia Risk Index with Time in Range for Assessing Glycemic Quality.
    Kim JY; Yoo JH; Kim JH
    Diabetes Technol Ther; 2023 Dec; 25(12):883-892. PubMed ID: 37668665
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypoglycemia and glycemic variability of people with type 1 diabetes with lower and higher physical activity loads in free-living conditions using continuous subcutaneous insulin infusion with predictive low-glucose suspend system.
    Montt-Blanchard D; Sánchez R; Dubois-Camacho K; Leppe J; Onetto MT
    BMJ Open Diabetes Res Care; 2023 Mar; 11(2):. PubMed ID: 36944432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 Diabetes.
    O'Neal DN; Cohen O; Vogrin S; Vigersky RA; Jenkins AJ;
    Diabetes Technol Ther; 2023 Feb; 25(2):108-115. PubMed ID: 36315189
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19.
    Gómez AM; Henao DC; Muñoz OM; Aschner P; Yepes CA; Jojoa R; Kerguelen A; Parra D; Jaramillo P; Umpierrez GE
    Diabetes Metab Syndr; 2021; 15(2):499-503. PubMed ID: 33662836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Hyperglycemia aversiveness": Investigating an overlooked problem among adults with type 1 diabetes.
    Polonsky WH; Fortmann AL; Price D; Fisher L
    J Diabetes Complications; 2021 Jun; 35(6):107925. PubMed ID: 33836966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-life 24-week changes in glycemic parameters among European users of flash glucose monitoring with type 1 and 2 diabetes and different levels of glycemic control.
    Lameijer A; Bakker JJ; Kao K; Xu Y; Gans ROB; Bilo HJG; Dunn TC; van Dijk PR
    Diabetes Res Clin Pract; 2023 Jul; 201():110735. PubMed ID: 37276981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous Glucose Monitoring Alarms in Adults with Type 1 Diabetes: User Characteristics and the Impact of Hypoglycemia and Hyperglycemia Alarm Thresholds on Glycemic Control.
    González-Vidal T; Rivas-Otero D; Agüeria-Cabal P; Ramos-Ruiz G; Delgado E; Menéndez-Torre E
    Diabetes Technol Ther; 2024 May; 26(5):313-323. PubMed ID: 38156962
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of COVID-19 lockdown on glucemic control in children and adolescents with type 1 diabetes mellitus.
    Sánchez Conejero M; González de Buitrago Amigo J; Tejado Bravo ML; de Nicolás Jiménez JM
    An Pediatr (Engl Ed); 2022 Jul; 97(1):22-29. PubMed ID: 35725820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring.
    Mesa A; Viñals C; Pueyo I; Roca D; Vidal M; Giménez M; Conget I
    Diabetes Res Clin Pract; 2020 Sep; 167():108354. PubMed ID: 32739380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of flash glucose monitoring in pregnant women with poorly controlled pregestational diabetes (FlashMom): A randomized pilot study.
    Tumminia A; Milluzzo A; Festa C; Fresa R; Pintaudi B; Scavini M; Vitacolonna E; Napoli A; Sciacca L
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1851-1859. PubMed ID: 33975741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitigation of hypoglycemia during Ramadan using the flash glucose monitoring system following dose adjustment of insulin and sulphonylurea in patients taking multiple glucose-lowering therapies (The PROFAST-IT Study).
    Elhadd T; Bashir M; Baager KA; Ali HA; Almohannadi DHS; Dabbous Z; Malik RA; Abou-Samra AB;
    Diabetes Res Clin Pract; 2021 Feb; 172():108589. PubMed ID: 33316309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.